Sanara Medtech Company Top Insiders
SMTI Stock | USD 27.38 1.00 3.79% |
Sanara Medtech employs about 141 people. The company is managed by 17 executives with a total tenure of roughly 25 years, averaging almost 1.0 years of service per executive, having 8.29 employees per reported executive. Assessment of Sanara Medtech's management performance can provide insight into the firm performance.
Shawn Bowman President President Wound Care Division |
Zachary Fleming President President Surgical Division |
Sanara Medtech Management Team Effectiveness
The company has return on total asset (ROA) of (0.0472) % which means that it has lost $0.0472 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2922) %, meaning that it created substantial loss on money invested by shareholders. Sanara Medtech's management efficiency ratios could be used to measure how well Sanara Medtech manages its routine affairs as well as how well it operates its assets and liabilities.Sanara Medtech Workforce Comparison
Sanara Medtech is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 16,807. Sanara Medtech maintains roughly 141 in number of employees contributing less than 1% to equities under Health Care industry.
The company has Profit Margin (PM) of (0.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09. Sanara Medtech Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sanara Medtech insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sanara Medtech's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Sanara Medtech insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Zachary Fleming a day ago Disposition of 717 shares by Zachary Fleming of Sanara Medtech at 41.5 subject to Rule 16b-3 | ||
Desutter Robert Andrew over two months ago Acquisition by Desutter Robert Andrew of 2444 shares of Sanara Medtech subject to Rule 16b-3 | ||
Jacob Waldrop over three months ago Disposition of 378 shares by Jacob Waldrop of Sanara Medtech at 29.38 subject to Rule 16b-3 | ||
Michael McNeil over three months ago Disposition of 687 shares by Michael McNeil of Sanara Medtech at 38.96 subject to Rule 16b-3 | ||
Michael McNeil over three months ago Acquisition by Michael McNeil of 1486 shares of Sanara Medtech subject to Rule 16b-3 | ||
Michael McNeil over three months ago Acquisition by Michael McNeil of 6547 shares of Sanara Medtech subject to Rule 16b-3 | ||
Michael McNeil over three months ago Disposition of 253 shares by Michael McNeil of Sanara Medtech at 22.97 subject to Rule 16b-3 | ||
Jacob Waldrop over three months ago Acquisition by Jacob Waldrop of 8790 shares of Sanara Medtech subject to Rule 16b-3 |
Sanara Medtech Notable Stakeholders
A Sanara Medtech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sanara Medtech often face trade-offs trying to please all of them. Sanara Medtech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sanara Medtech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Ronald Nixon | Executive Chairman of the Board | Profile | |
Shawn Bowman | President Wound Care Division | Profile | |
Seth Yon | President Commercial | Profile | |
David Strasfeld | President Healing | Profile | |
Zachary Fleming | President Surgical Division | Profile | |
Rebecca Mcmahon | President Development | Profile | |
Bill Fitzgerald | Compliance Officer | Profile | |
Suresh Muppalla | Executive Officer | Profile | |
Jacob Waldrop | Chief Officer | Profile | |
Callon Nichols | Director Relations | Profile | |
Elizabeth Taylor | Chief Officer | Profile | |
Jane Fore | Chief Officer | Profile | |
Tricia Matteson | Director Marketing | Profile | |
Michael McNeil | Chief Secretary | Profile | |
Tyler Palmer | Chief Officer | Profile | |
Carla Day | Director Services | Profile | |
FACHM FAPWCA | Pres Services | Profile |
About Sanara Medtech Management Performance
The success or failure of an entity such as Sanara Medtech often depends on how effective the management is. Sanara Medtech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sanara management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sanara management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas. Sanara Medtech operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 63 people.
Sanara Medtech Workforce Analysis
Traditionally, organizations such as Sanara Medtech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sanara Medtech within its industry.Sanara Medtech Manpower Efficiency
Return on Sanara Medtech Manpower
Revenue Per Employee | 614.7K | |
Revenue Per Executive | 5.1M | |
Net Loss Per Employee | 70.3K | |
Net Loss Per Executive | 583.1K | |
Working Capital Per Employee | 127.8K | |
Working Capital Per Executive | 1.1M |
Complementary Tools for Sanara Stock analysis
When running Sanara Medtech's price analysis, check to measure Sanara Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanara Medtech is operating at the current time. Most of Sanara Medtech's value examination focuses on studying past and present price action to predict the probability of Sanara Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanara Medtech's price. Additionally, you may evaluate how the addition of Sanara Medtech to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |